Skip to content

Modification of Rhythmic Risk Assessment by Ventricular Tachycardia Ablation

Modification of Rhythmic Risk Assessment by Ventricular Tachycardia Ablation

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03453645
Enrollment
30
Registered
2018-03-05
Start date
2017-09-09
Completion date
2019-02-28
Last updated
2018-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventricular Tachycardia

Keywords

ablation, sudden death, signal averaged ECG, T wave alternans, heart rate variability

Brief summary

Sudden cardiac death is a frequent cause of cardiovascular mortality. Numerous rhythmic risk assessment criterion have been described targeting the substratum, the cardiac nervous tone or the trigger of arrhythmias. Development of ventricular tachycardia ablation in the past few years show interesting results preventing the recurrence of ventricular arrhythmias.

Detailed description

Sudden cardiac death is a frequent cause of cardiovascular mortality. Numerous rhythmic risk assessment criterion have been described targeting the substratum, the cardiac nervous tone or the trigger of arrhythmias. Development of ventricular tachycardia ablation in the past few years show interesting results preventing the recurrence of ventricular arrhythmias. Rhythmic risk assessment criterions have never been studied in relation with ventricular tachycardia ablation. The purpose of this study is to explore the modifications of these criterions after ventricular tachycardia ablation.

Interventions

The usual organization of hospitalization of the patients addressed for ventricular tachycardia ablation and his follow-up are not modified by the protocol. .

Sponsors

University Hospital, Toulouse
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients undergoing ventricular tachycardia, * patients with ischemic cardiomyopathy according to European Society of Cardiology Guidelines, * patients with implanted cardiac defibrillator.

Exclusion criteria

* Contra-indication to stress test, * permanent atrial fibrillation, * permanent ventricular pacing, * left bundle block.

Design outcomes

Primary

MeasureTime frameDescription
measure assessing change before and after Ventricular Tachycardia Ablation of the non-invasive parameters analysis of the rhythmic risk before and after Ventricular Tachycardia Ablation10 minutes and 60 minutes after the Ventricular Tachycardia Ablationnon invasive parameters analysis of the rhythmic risk will be evaluated by the evaluation of the T wave alternans

Secondary

MeasureTime frameDescription
Assessing the correlations of the modifications of the risk criterion after ablation with the recurrences of arrhythmias at one year follow-up3 months, 6 months and 12 months after the Ventricular Tachycardia Ablationthe recurrences of arrhythmias will be evaluated . There will be assessed by the informations reveled by the Implantable automatic defibrillator
Study of the correlation between the modifications of non-invasive parameters analysis of the rhythmic risk and the success of the ablation procedure3 months, 6 months and 12 months after the Ventricular Tachycardia AblationSuccess of the ablation procedure is defined by the absence of inducible Ventricular Tachycardia at the end of the procedure.

Countries

France

Contacts

Primary ContactPhilippe MAURY, MD
maury.p@chu-toulouse.fr05 61 32 31 00
Backup ContactIsabelle OLIVIER, PhD
olivier.i@chu-toulouse.fr05 61 77 70 51

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026